Herborium Engages Investor and Media Relations
October 21 2010 - 12:00PM
Herborium Group, Inc., (Pink Sheets:HBRM) www.herborium.com, a
Botanical Therapeutics™ company, today announced it has retained
SmallCap Support Services, a Houston based investor, media, and
public relations firm.
"I am pleased to engage SmallCap Support Services to handle our
growing investor relations needs and increase our trade &
popular press coverage," commented Dr. Agnes P. Olszewski,
Herborium Group's president and chief executive officer. "SmallCap
ensures all Company information released will be clear and
accurately conveyed.
"Herborium develops and markets novel, clinically tested
Botanical Therapeutics® (botanical medicines), a distinctly
separate product classification compared to simple nutraceuticals.
Our products' differential advantage rests in clinical testing of
its safety and efficacy and drives product development
opportunities by the use of U.S. Food & Drug Administration
(2004) and European Medicines Agency guidelines.
"Therefore, we required an IR/PR firm with the capacity to
develop a working knowledge of Herborium and our products'
differential market advantages. After careful consideration, I am
pleased to announce SmallCap is such a firm.
"As we finalize marketing plans, I expect further personnel will
also be needed to support our new product exposure initiatives, in
particular, Herborium's new 2011 U.S. marketing campaign to
aggressively promote its flagship product, AcnEase®."
AcnEase is a proprietary, botanical therapeutic product taken
orally that prevents acne from forming in both females and males of
all ages. Furthermore, AcnEase has been proven safe and effective
in the treatment of both acne and rosacea through rigorous clinical
testing (www.acnease.com).
"Roche's Accutane® was the leading prescriptive oral acne
medication, until being removed from the market due to serious
side-effects. The withdrawal of Accutane has presented Herborium
with an enormous opportunity to capture market share with AcnEase
-- the only all-natural, safe, and effective oral acne
medicine."
"In conclusion, I look forward to soon sharing updates on
AcnEase as well as our international sales," Olszewski
concluded.
About SmallCap Support Services
SmallCap Support Services is a Houston-based boutique investor
relations firm offering a full-range of services to emerging public
companies primarily in the Technology, Oil & Gas, Telecom,
Medicine, Entertainment, and Defense & Aerospace sectors.
SmallCap Support Services works with both development stage and
growth stage public companies delivering a full spectrum of
affordable investor, public and media relations services. The
firm takes on only a small number of honest, hardworking, and
innovative clients, and then focuses passionately on their investor
relations goals with professionalism, honesty, and integrity of
method. For more information, please visit www.smallcapss.com.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company business model focuses on emerging
market opportunities spearheaded by the growth of a new market
sector located between high-cost, high-risk, ethical
pharmaceuticals and commoditized classic nutraceuticals
(supplements). The Company uses clinical validation and a
proactive regulatory strategy based on the FDA Guidance for
Industry: Botanical Drug Products (FDA Guidance 2004) to establish
and maintain a differential advantage. For more information, please
visit www.herborium.com and www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are based
on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or
"intends." We cannot promise future returns. Our statements
reflect our best judgment at the time they are issued, and we
disclaim any obligation to update or alter forward-looking
statements as the result of new information or future
events. The Company urges investors to review the risks and
uncertainties contained within its filings with the OTC Markets
and/or Securities and Exchange Commission.
CONTACT: Herborium Group, Inc.
Media Relations
Steve Haag
(832) 413-6206
Herborium (PK) (USOTC:HBRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Herborium (PK) (USOTC:HBRM)
Historical Stock Chart
From Jul 2023 to Jul 2024